Asarina Pharma Company

Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders.

Founded Date: 01-01-2006
Last Funding Type: Post-IPO Equity
Headquarters: Solna, Stockholms Lan, Sweden
Investors Number: 4
Employee Number: 1-10
Industry: General Health Care
Estimated Revenue: Less than $1M
Last Funding Date: 2018-09-20
Funding Status: IPO
Total Funding: $24,828,814